Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2080 studies found for:    docetaxel
Show Display Options
Rank Status Study
1 Completed Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events
Conditions: CYP3A Phenotyping;   CYP3A5 and MDR1 Genotyping;   Docetaxel Toxicity;   Associations Between Genetic Data and Docetaxel Toxicity
Intervention: Drug: docetaxel + CEF
2 Completed A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients
Condition: Hormone-Refractory Prostate Cancer
Intervention: Drug: Docetaxel, Carboplatin
3 Completed Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Cancer
Interventions: Drug: docetaxel;   Drug: NPI-2358 + docetaxel
4 Unknown  Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer
Condition: Hormone Refractory Prostate Cancer
Interventions: Drug: Docetaxel * Sunitinib;   Drug: Docetaxel
5 Completed Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: IPI-504, docetaxel
6 Active, not recruiting Docetaxel and Lycopene in Metastatic Prostate Cancer
Condition: Adenocarcinoma of the Prostate
Intervention: Drug: Lycopene and Docetaxel
7 Terminated Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Drug: Docetaxel
8 Completed Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle
Condition: Solid Tumors
Intervention: Drug: Docetaxel (Taxotere®)
9 Completed Phase I Study of LB-100 With Docetaxel in Solid Tumors
Conditions: Tumors;   Neoplasms;   Cancer
Interventions: Drug: LB-100 for Injection;   Drug: Docetaxel
10 Unknown  Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients
Condition: Prostate Cancer
Interventions: Drug: Docetaxel every 3 weeks + Prednisone;   Drug: Docetaxel weekly+ Prednisone
11 Unknown  Secondary Adjuvant Treatment for Patients With Isolated Tumor Cells in Bone Marrow
Condition: Breast Cancer
Intervention: Drug: Docetaxel
12 Completed The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
Condition: Nausea and Vomiting, Chemotherapy-Induced
Interventions: Drug: Docetaxel;   Drug: Casopitant/Docetaxel
13 Completed Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: Celecoxib;   Drug: Docetaxel
14 Completed Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers
Condition: Metastatic Breast Cancer
Interventions: Drug: Capecitabine;   Drug: Docetaxel
15 Completed RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer
Condition: HEAD & NECK Cancer
Intervention: Drug: RAD001 + docetaxel + cisplatin
16 Completed
Has Results
Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Docetaxel and Cisplatin
17 Completed Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Gemcitabine, Docetaxel
18 Terminated
Has Results
Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores
Conditions: Breast Neoplasms;   Breast Cancer;   Cancer of the Breast
Interventions: Drug: Docetaxel with Cytoxan;   Drug: Dexamethasone
19 Recruiting Docetaxel and S-1 for Advanced Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: DS (docetaxel+S-1)
20 Terminated A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED)
Conditions: Prostate Cancer;   Breast Cancer;   Ovarian Cancer;   Lung Cancer;   Gastric Cancer
Intervention: Drug: Docetaxel plus lonafarnib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.